X0306 4 2019-01-28 0001281895 ROCKET PHARMACEUTICALS, INC. RCKT 0001726398 Schwartz Jonathan David C/O ROCKET PHARMACEUTICALS, INC. 350 FIFTH AVENUE, SUITE 7530 NEW YORK NY 10118 true Chief Medical Officer Stock Option (Right to Buy) 14.56 2019-01-28 4 A 0 75000 0 A 2029-01-28 Common Stock 75000 75000 D This option represents a right to purchase a total of 75,000 shares of the Issuer's Common Stock, 25,000 of which will become fully vested and exercisable on January 28, 2020, with the remaining 50,000 shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer. Exhibit 24 - Power of Attorney /s/ Sara Turken, as attorney-in-fact for Jonathan Schwartz 2019-01-30